Terms: = Ovarian cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10 AND Prognosis
3 results:
1. Expression of epithelial-mesenchymal transition biomarkers: Discoidin domain receptor 2, Snail-1, and Ovol-2 as predictors of clinical outcome in patients with epithelial ovarian carcinoma.
Harb OA; Elfeky MA; El-Beshbishi W; Obaya AA; Abdallah WM; Ibrahim A; Awd AA; Embaby A
J Cancer Res Ther; 2022; 18(4):1073-1082. PubMed ID: 36149163
[TBL] [Abstract] [Full Text] [Related]
2. Role of discoidin domain receptor 2 (ddr2) and microRNA-182 in survival of women with high-grade serous ovarian cancer.
Ramalho S; Andrade LAA; Filho CC; Natal RA; Pavanello M; Ferracini AC; Sallum LF; Sarian LO; Derchain S
Tumour Biol; 2019 Jan; 41(1):1010428318823988. PubMed ID: 30810094
[TBL] [Abstract] [Full Text] [Related]
3. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
Rada M; Nallanthighal S; Cha J; Ryan K; Sage J; Eldred C; Ullo M; Orsulic S; Cheon DJ
Oncogene; 2018 Aug; 37(35):4809-4820. PubMed ID: 29769618
[TBL] [Abstract] [Full Text] [Related]
